Aureate Tradde IPO—Company Analysis
The Aureate Tradde IPO is a fixed price issue under the SME IPO category, amounting to Rs. 27.29 crores. Aureate Tradde Limited is engaged in the supply, distribution, and trade of industrial and technology materials within the domestic market. The company operates in three primary sectors: polymers and petrochemicals, lithium-ion and sodium-ion cells, and chargers for electric vehicles.
The offerings include PVC resins, PET resins, polyethylene (both LDPE and HDPE grades), lithium-ion and sodium-ion cells, as well as lithium and lead-acid chargers and EV chargers. Using an inventory-based model, the company pre-purchases and holds inventory to fulfill orders for clients in the small, medium, and large business sectors.
The company operates mainly in the domestic B2B market for polymers, petrochemicals, lithium-ion cells, and sodium-ion cells and in both the B2B and B2C markets for electric vehicle chargers.
Aureate Tradde IPO Details
The Aureate Tradde IPO opens on May 29, 2026, with the public offer closing on June 2. The IPO allotment is on June 3, and refunds are initiated on June 4, 2026.
The issue is a completely fresh issue of 0.39 crore shares, with an offer size of Rs. 27.29 crores.
The expected date for the Aureate Tradde IPO listing is June 5, 2026, and will be listed on BSE and SME.
The Aureate Tradde IPO price band is Rs. 70.
IPO Timetable (Tentative)
Click to open free demat account and apply for the IPO.
Company Financials
(Amount in Cr)
Cash Flows
(Amount in lac)
Revenue Bifurcation
(Rs. in Lac)
(Source: RHP)
Objective of the Issue
The Company intends to use the Net Proceeds from the Issue for the following purposes:
Funding the working capital needs of the Company. ~ Rs. 10 Cr.
Repayment/prepayment, in full or in part, of certain borrowings availed by the Company. ~ Rs. 9.93 Cr.
To meet the General Corporate Purposes. ~ Rs. 4.09 Cr.
General Corporate purposes.
Listed Peers of Aureate Tradde Ltd.
Valuation
Evaluation of P/E Ratio
For the period ended FY 2025, with an EPS of Rs. 2.83 from the previous year, the P/E ratio would be 24.73x.
IPO's Strengths
Warehouses and depots in a strategically advantageous location.
Promoters who are experienced and have a vision.
A strong financial history.
Presence in multiple industries.
Established long-term relationships with clients.
IPO's Weaknesses
Products rely on imports.
No long-term agreements with customers.
Reliance on third-party manufacturing.
Aureate Tradde IPO GMP (Grey Market Premium)
As of 27 May 2026, Aureate Tradde IPO GMP has not yet begun.
Aureate Tradde IPO Summary
IPO Lot Details
For retail investors, the minimum and maximum number of Lots in which they can apply is 2 Lots (4000 Shares) for Rs. 2,80,000 and in multiples of that, while for HNI investors, the minimum number of Lots in which they can apply is 3 Lots (6000 Shares) for Rs. 4,20,000.
Aureate Tradde IPO Allotment Status
You can check Aureate Tradde IPO Allotment Status on the official Registrar's websites and the BSE website. Below are the links for your reference.
Using BSE Website - BSE IPO allotment status
Promoters And Management of Aureate Tradde Ltd.
Mr. Kalash Kevin Shah
Mr. Punit Devendrabhai
IPO Lead Managers
Corporate Makers Capital Ltd.
Dividend Policy
The company has not declared any dividend in the past three financial years.
Conclusion
Aureate Tradde has publicly listed on the trade market at a fixed issue price of ₹70 with an expected market size of ₹27.29 Cr for their SME IPO. The offer opens on 29th May 2026, closes on 2nd June 2026, and the company's shares are expected to be released to the market on 5th June 2026. The company estimates a profit growth of their first financial year of ₹2.57 Cr with an estimated ROE of 21.88%, ROCE of 20.56% with a P/E of 24.73x. There are financial risks of presenting a ratio of debt to equity of 2.49 along with cash flow weaknesses.
The IPO has several promising aspects such as a well diversified business, the experience of the promoters & a proven history of stable performances. There are several risks investors should consider such as dependence on exports, no long-lasting contracts with customers, dependence on third parties for manufacturing, and GMP has not started yet.
To read the prospectus of the company click here to download the DRHP.
DISCLAIMER: This blog does not constitute any buy or sell recommendation. No investment or trading advice is being provided. The content is intended solely for educational and informational purposes. Investors should consult a qualified financial advisor before making any investment decisions.
